Place of radiotherapy for treatment of metastatic cervical, vaginal and endometrial uterine cancer

Cancer Radiother. 2023 Jul 26:S1278-3218(23)00125-7. doi: 10.1016/j.canrad.2023.06.012. Online ahead of print.ABSTRACTBeyond classical palliative-intent irradiation schemes, there are increasing data suggesting a benefit for intensive locoregional treatments in metastatic gynecological cancers. Such approach aims at avoiding local symptoms related to tumor progression, but may also improve survival outcome by shrinking tumor burden to a microscopic state. This strategy is rarely considered upfront (in highly selected patients with very limited oligometastatic disease), but rather after systemic treatment. In case of tumor response (especially if complete response) of the metastatic sites, pelvic±para-aortic radiotherapy can be considered in combination with a brachytherapy boost to obtain long-term local control, in particular in cervical or vaginal cancer patients. Such approach seems particularly relevant when there is isolated persistence or progression of macroscopic disease within the pelvis. In parallel, there is also an increasing place for radiotherapy of oligo-metastatic sites. We review the literature on the place of radiotherapy in the management of cancers of the cervix and metastatic endometrial cancer.PMID:37507287 | DOI:10.1016/j.canrad.2023.06.012

Source: Cancer Radiotherapie - July 28, 2023 Category: Cancer & Oncology Authors: A Escande J Leblanc J-M Hannoun-Levi S Renard A Ducassou C Hennequin C Chargari Source Type: research